VALIDATION DATA

MEASUREMENT PROPERTIES
Limitations
Observations

The recall period for items is at least three times per week during the last month, which corresponds to criterion B of the ICD-10 for insomnia.

1. RELIABILITY
A. Internal Consistency Tested
Cronbach's (Describe)

Cronbach’s α was 0.87 (AIS-5) to 0.89 (AIS-8) in the original cohort

B. Reliability intraobserver or test-retest Tested
Continuous scores: intraclass
correlation coefficient (ICC)
Dichotomus: Cohen kappa (Describe)

Pearson’s correlation coefficient was 0.88 (AIS-5) to 0.89 (AIS-8) for questionnaires administered 1 week apart. For a longer period of test-retest reliability at a mean of 81 days in a chronic pain population, the ICC was 0.64 for the AIS-8

C. Reliability interobserver or Measurement error Not Tested
Standard error of measurement (SEM),
smallest detectable change (SDC) or
Limits of agreement (LoA) (Describe)
2. VALIDITY
A. Content validity: face validity Tested
Expert opinion (relevance and
comprehensiveness) (Describe)

The AIS has high face validity because the items match ICD-10 criteria for nonorganic insomnia. Notably, the International Classification of Sleep Disorders, version 3 (ICSD-3) does not differentiate between organic, nonorganic, or other subtypes of insomnia (except acute or chronic) and has different diagnostic criteria compared with ICD10. The DSM-5 similarly removed the distinction between primary and secondary insomnia and has different diagnostic criteria compared with ICD-10. Because the ICSD-3 and DSM-5 are used more widely in sleep medicine, the face validity of the AIS may be decreased, compared with these updated diagnostic criteria

B. Construct Validity:
Structural validity
Not Tested
Hypotheses-testing Tested
Cross-cultural validity Tested
Brief Description
C. Criterion validity Tested
Comparison with a 'gold standard' Continuous scores:
correlations, ROC curves Dichotomus:
Sensitivity & Specificity (Describe)

Using a cutoff of 6 or higher, the AIS-8 distinguished individuals with insomnia from those without insomnia with a sensitivity of 93% and specificity of 85% in the original validation cohort. The original validation cohort consisted of 176 individuals with insomnia and 123 individuals without insomnia who were diagnosed according to a nonstructured clinical interview, with the diagnosis based on ICD-10 criteria. This cohort was composed of 105 patients presenting to a primary health clinic with a complaint of insomnia without an obvious cause, 144 psychiatric patients, and 50 nonpatient controls.